Plasma exchange therapy inhibited the progression of anti-MAG antibody-associated polyneuropathy-Reference-Cited by-同舟云学术

Plasma exchange therapy inhibited the progression of anti-MAG antibody-associated polyneuropathy

Published:2020 Issue:11 Volume:53 Page:553-558
ISSN:1340-3451
Container-title:Nihon Toseki Igakkai Zasshi
language:en
Short-container-title:Nihon Toseki Igakkai Zasshi

Author:

Nakajima Eriko¹,Karube Miho¹,Nakajima Masanori²,Shimoda Sachiko¹,Kunitomo Rie¹,Heryong Lee¹,Miyamoto Ayako¹,Takemori Ai¹,Kobayashi Satoshi¹,Kukimoto Hikaru¹,Uchibori Ayumi²,Ichikawa Yaeko²,Chiba Atsuro²,Komagata Yoshinori¹,Kaname Shinya¹

Affiliation:

1. Department of Nephrology and Rheumatology, Kyorin University School of Medicine

2. Department of Neurology, Kyorin University School of Medicine

Publisher

Japanese Society for Dialysis Therapy

Subject

Organic Chemistry,Biochemistry

Link

https://www.jstage.jst.go.jp/article/jsdt/53/11/53_553/_pdf

Reference15 articles.

1. 6) Lunn MP, Nobile-Orazio E. Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies. Cochrane Database Syst Rev 2016; 10: CD002827.

2. 7) Nobile-Orazio E, Bianco M, Nozza A. Advances in the Treatment of Paraproteinemic Neuropathy. Curr Treat Options Neurol 2017; 19: 43.

3. 8) Gazzola S, Delmont E, Franques J, et al. Predictive factors of efficacy of rituximab in patients with anti-MAG neuropathy. J Neurol Sci 2017; 377: 144-8.

4. 9) Kawagashira Y, Koike H, Ohyama K, et al. Axonal loss influences the response to rituximab treatment in neuropathy associated with IgM monoclonal gammopathy with antimyelin-associated glycoprotein antibody. J Neurol Sci 2015; 348: 67-73.

5. 10) Benedetti L, Briani C, Franciotta D, et al. Long-term effect of rituximab in anti-mag polyneuropathy. Neurology 2008; 71: 1742-44.